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OBJECTIVES This quantitative angiographic and intravascular ultrasound study determined the mecha-
nisms of acute lumen enlargement and recurrent restenosis after rotational atherectomy (RA)
with adjunct percutaneous transluminal coronary angioplasty in the treatment of diffuse
in-stent restenosis (ISR).
BACKGROUND In-stent restenosis remains a significant clinical problem for which optimal treatment is under
debate. Rotational atherectomy has become an alternative therapeutic approach for the
treatment of diffuse ISR based on the concept of “tissue-debulking.”
METHODS Rotational atherectomy with adjunct angioplasty of ISR was used in 45 patients with diffuse
lesions. Quantitative coronary angiographic (QCA) analysis and sequential intravascular
ultrasound (IVUS) measurements were performed in all patients. Forty patients (89%)
underwent angiographic six-month follow-up.
RESULTS Rotational atherectomy lead to a decrease in maximal area of stenosis from 80 6 32% before
intervention to 54 6 21% after RA (p , 0.0001) as a result of a significant decrease in intimal
hyperplasia cross-sectional area (CSA). The minimal lumen diameter after RA remained
15 6 4% smaller than the burr diameter used, indicating acute neointimal recoil. Additional
angioplasty led to a further decrease in area of stenosis to 38 6 12% due to a significant
increase in stent CSA. At six-month angiographic follow-up, recurrent restenosis rate was
45%. Lesion and stent length, preinterventional diameter stenosis and amount of acute
neointimal recoil were associated with a higher rate of recurrent restenosis.
CONCLUSIONS Rotational atherectomy of ISR leads to acute lumen gain by effective plaque removal. Adjunct
angioplasty results in additional lumen gain by further stent expansion and tissue extrusion.
Stent and lesion length, severity of ISR and acute neointimal recoil are predictors of recurrent
restenosis. (J Am Coll Cardiol 1999;34:33–9) © 1999 by the American College of
Cardiology
Coronary stent implantation has markedly improved acute
and long-term outcome after coronary angioplasty (1,2).
Widening of the indication for stent implantation (3) led to
a significant increase in implantation numbers and disclosed
in-stent restenosis (ISR) as a new, iatrogenic entity, which
developed into a considerable problem in interventional
cardiology. In contrast to angioplasty, where restenosis is
predominantly caused by elastic recoil and vascular remod-
eling, ISR is almost exclusively attributable to neointimal
hyperplasia (4,5). The optimal percutaneous treatment of
ISR remains unclear, especially when it presents as a severe
and diffuse process. At present, additional angioplasty is the
treatment of choice for focal lesions (6,7). In long and
diffuse restenotic stents, however, angioplasty may result in
unacceptably high restenosis rates of up to 80% (8). There-
fore, debulking techniques (excimer laser angioplasty, direc-
tional coronary atherectomy, rotational atherectomy), ablat-
ing intrastent neointimal tissue before adjunct angioplasty,
may have theoretical advantages.
Rotational atherectomy (RA) has primarily been designed
for “differential cutting,” the treatment of heavily calcified
lesions in native coronary arteries (9,10). Previous intravascular
ultrasound (IVUS) studies, however, have shown that RA also
effectively ablates noncalcified plaque (11), implicating a po-
tential role for this technique in the treatment of ISR.
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The purpose of the present study was to use serial
intravascular ultrasound analysis as well as quantitative
coronary angiography (QCA) to assess the mechanisms of
acute lumen gain after RA with additional angioplasty in
the treatment of diffuse ISR. In addition, systematic angio-
graphic follow-up was performed to identify clinical, pro-
cedural, angiographic and IVUS predictors of recurrent
restenosis.
METHODS
Patient and lesion characteristics. A total of 45 patients
(49 lesions) with a mean age of 60 6 11 years (29 men, 16
women) were studied. Their cardiovascular risk profile was:
89% arterial hypertension, 82% hypercholesterolemia, 51%
smokers and 38% diabetics. Forty patients presented with
stable angina; the remaining had unstable angina. The mean
total stent length was 29.5 6 19.2 mm (range 7 to 65 mm),
and consisted of 2.1 6 1.2 (range 1 to 6) primarily
implanted stents per lesion (mean balloon size for implan-
tation: 3.0 6 0.7 mm). There were 37 Palmaz-Schatz, 44
ACS MultiLink, 14 PURA and 8 Wallstents. The mean
lesion length was 22.4 6 20.2 mm, with 46/49 (94%)
lesions .10 mm, indicating diffuse ISR. Arteries treated
and imaged were left anterior descending in 19, left circum-
flex in 9 and right coronary artery in 17 patients. None of
the lesions was in a saphenous vein graft or ostial in location.
Rotational atherectomy was performed 7.3 6 1.0 months
after primary stent implantation. Measurements of creatine
kinase were performed at baseline, and 6 and 12 h postpro-
cedure. Follow-up angiography was obtained in 40/45
patients (89%) at 5.8 6 1.5 months after repeat interven-
tion. Clinical follow-up for the remaining five patients was
completed by telephone contact.
Patients were prospectively studied with a protocol that
had been approved by the institutional ethics committee and
patients gave written informed consent before participation.
Rotational atherectomy with adjunct angioplasty proce-
dure. Details of the rotablator technique have been de-
scribed elsewhere (9,10). In contrast to RA in native
coronary arteries, the system (Rotablator system, Scimed,
Redmond, Washington) was adjusted to a submaximal
rotational speed between 150,000 and 170,000 rounds per
minute, taking great care to avoid drops .5,000 rounds.
Advancement distal to the stenosis into the previously
untreated and unstented vessel segment was carefully
avoided. Intracoronary nitroglycerin was given liberally in
0.2-mg bolus doses before and after each passage. A step
approach with increasing burr sizes and 2.3 6 1.0 burrs/
lesion (range 1 to 4) with a mean burr size of 1.9 6 0.5 mm
(range 1.25 to 2.38 mm) and a final burr size of 2.05 6
0.5 mm was performed. The final burr/artery (stent) ratio by
IVUS measured 0.8 6 0.4. Adjunct balloon angioplasty
(maximum pressure: 7 6 1 atm) was performed with a mean
balloon size of 3.0 6 0.6 mm (balloon/artery ratio: 1.3 6
0.3).
Quantitative coronary angiography analysis: procedural
success and recurrent restenosis. Quantitative coronary
angiography analysis was performed off-line with an auto-
mated edge-detection algorithm (CAAS II System, Pie-
Medical, Maastricht, The Netherlands) with the outer
diameter of the contrast-filled catheter used as the calibra-
tion standard. The following measurements were obtained:
reference diameter, minimal lumen diameter (MLD) within
the lesion (mm), mean (overall) luminal diameter of the
total stent length (mm) and percent diameter stenosis before
intervention, after RA, after angioplasty and at follow-up in
multiple projections. The results from the worst view were
analyzed. The lesion length was measured as the distance
from shoulder to shoulder in all available projections. The
longest lesion length was recorded to avoid effects of
foreshortening. Due to the complexity and length of many
of the lesions with involvement of adjacent segments prox-
imal and distal, a user-defined reference luminal diameter of
a proximal and distal angiographically normal appearing
segment was chosen.
Procedural success was defined as a final diameter stenosis
,50% without major in-hospital complications (death,
bypass surgery, additional angioplasty or Q-wave myocar-
dial infarction). Recurrent restenosis after RA at follow-up
angiography was defined as $50% diameter stenosis.
Intravascular ultrasound imaging protocol. Studies were
performed using a single-element 30-MHz transducer
within either a 2.9-F long monorail/common distal lumen
imaging sheath or within a 3.2-F short monorail imaging
sheath (Boston Scientific Corp.) and an automated pullback
with a speed of 0.5 mm/s to obtain a complete and
homogeneous image sequence.
Intravascular ultrasound imaging was started 2 min after
intracoronary administration of 0.2 mg nitroglycerin. The
ultrasound catheter was advanced beyond the target lesion
and an imaging run was performed to the aorto-ostial
junction. Image quality was adjusted to the relatively low
echogenic in-stent neointima during catheter advancement
to ensure optimal visualization. Studies were recorded dur-
ing transducer pullback on high resolution S-VHS tape for
off-line analysis.
Abbreviations and Acronyms
CSA 5 cross-sectional area
EEM 5 external elastic membrane
IH 5 intimal hyperplasia
ISR 5 in-stent restenosis
IVUS 5 intravascular ultrasound
MLD 5 minimal lumen diameter
QCA 5 quantitative coronary angiography
RA 5 rotational atherectomy
34 Radke et al. JACC Vol. 34, No. 1, 1999
Rotational Atherectomy for Restenosis July 1999:33–9
Quantitative IVUS measurements. The method of IVUS
measurements has been validated in vivo and in vitro
(12–14). In-stent restenosis length was defined as the axial
length of the stent (in millimeters) before intervention in
which intimal hyperplasia (IH) cross-sectional area (CSA)
occupied .75% stent CSA. The off-line planar IVUS
measurements (in mm2) were traced in 1-mm increments
and included: 1) lumen CSA; 2) stent CSA, and 3) external
elastic membrane (EEM) CSA. The IH CSA was defined
as the stent CSA minus lumen CSA, and peristent plaque
was defined as EEM CSA minus stent CSA. The minimal
and the mean lumen CSA within the stent were obtained
for calculations of the pre- and postprocedural maximal and
mean area stenosis. The lumen, stent, IH, peristent plaque
and EEM CSA of the whole stent length were averaged per
patient and compared before intervention versus after RA
(maximal burr size), after RA versus after angioplasty and
preintervention versus after angioplasty (postintervention).
In addition, serial analysis (before intervention, after RA,
after angioplasty) was performed to separate the contribu-
tion of 1) tissue ablation, 2) stent expansion and 3) tissue
extrusion to the overall periprocedural lumen gain.
The MLD was defined as the smallest lumen diameter
over the whole stent length and was used for calculations of
acute neointimal recoil after RA. Recoil was defined as a
burr size (diameter in mm)/MLD (mm) ratio .1. When
the plaque encompassed the IVUS imaging catheter, the
lumen diameter and CSA were assumed to be the size of the
catheter. The reference segments selected were the most
normal appearing cross sections within 10 mm proximal and
distal of the stented segment.
Statistical analysis. Statistical analysis was performed us-
ing SPSS for Windows 7.5 (SPSS, Chicago, Illinois) and
SAS (Statistical Analysis System, Cary, North Carolina).
Continuous data are presented as mean 6 SD. Compari-
sons between groups were performed by use of paired or
unpaired t tests or analysis of variance for repeated measures
with post hoc analysis for continuous variables. Qualitative
data are presented as frequencies and comparison between
quantitative data was performed with chi-square statistics.
Initially, simple linear regression analysis was performed to
evaluate the relationship between the minimal lumen diam-
eter obtained by IVUS and QCA. Furthermore, the limits
of agreement between pairs of measurements were deter-
mined according to the method described by Bland and
Altman (15). The mean difference between the methods
investigated is the systematic error (bias) and two standard
deviations are defined as limits of agreement (95% confi-
dence interval). Predictors of restenosis were calculated by
univariate and multivariate logistic regression analysis. A p
value ,0.05 was considered statistically significant.
RESULTS
Procedural results. Procedural success was achieved in all
patients. All QCA measurements are listed in Table 1.
There were no significant creatine kinase elevations or major
in-hospital complications (death, bypass surgery, additional
angioplasty or Q-wave myocardial infarction). Patients were
discharged 2.5 6 1.0 days after the procedure.
Mechanisms of rotablation and adjunct angioplasty. Pla-
nar intravascular ultrasound measurements (Table 1) re-
vealed a significant increase in minimal lumen CSA by
rotablation. This acute lumen gain was a result of a decrease
in IH CSA. The stent CSA, the peristent plaque CSA and
the EEM CSA did not change significantly from baseline to
Table 1. Quantitative Angiography Acute and Follow-up Results (40 Patients) and Planar Intravascular Ultrasound (45 Patients)
Procedural Results of Rotational Atherectomy With Adjunct Percutaneous Transluminal Coronary Angioplasty (PTCA) for Diffuse
In-Stent Restenosis
QCA Results (mm) Preintervention
Intervention
Follow-upAfter RA After PTCA
Reference diameter 2.22 6 0.31 2.20 6 0.24 2.30 6 0.32 2.20 6 0.31
MLD 0.57 6 0.35 1.52 6 0.29 1.89 6 0.21 1.05 6 0.34
Diameter stenosis (%) 74 6 26 31 6 18 18 6 14 52 6 23
Planar IVUS results (mm2) p (ANOVA)
Reference lumen CSA 6.72 6 0.40 6.85 6 0.41 6.90 6 0.44 NS
Minimal lumen CSA 1.35 6 1.28 3.17 6 0.70* 4.28 6 0.61* ,0.0001
Mean lumen CSA 2.96 6 1.10 3.67 6 0.73† 4.81 6 0.70* ,0.0001
Stent CSA 7.59 6 0.78 7.60 6 0.72 8.49 6 0.48* ,0.0001
Intimal hyperplasia CSA 4.63 6 0.98 3.94 6 0.69† 3.68 6 0.80 ,0.0001
Peristent plaque CSA 8.13 6 2.17 8.34 6 1.99 9.67 6 1.86† ,0.001
EEM CSA 15.71 6 4.46 15.93 6 4.81 18.15 6 2.84† ,0.01
Area stenosis, max. (%) 80 6 32 54 6 21* 38 6 12† ,0.0001
Area stenosis, mean (%) 56 6 36 46 6 29 30 6 19† ,0.0001
*p , 0.0001; †p , 0.01, compared from preintervention to after rotational atherectomy (RA) or from after RA to after PTCA. All data are expressed as mean area 6 standard
deviation. ANOVA 5 analysis of variance; CSA 5 cross-sectional area; EEM 5 external elastic membrane; IVUS 5 intravascular ultrasound; max. 5 maximum; MLD 5
minimal lumen diameter; QCA 5 quantitative coronary angiography; RA 5 rotational atherectomy.
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after RA. The MLD after RA as assessed by IVUS (1.75 6
0.34 mm) remained 15 6 4% smaller than the burr diameter
used (final burr size: 2.05 6 0.5 mm), indicating acute
plaque recoil. The mean lumen diameter (2.25 6 0.22 mm)
was 10 6 5% larger than the final burr size used.
After adjunct angioplasty the minimal lumen CSA in-
creased significantly as a result of an increase in stent CSA
and a decrease in IH CSA. Conversely, the maximal area of
stenosis decreased from 54 6 21% to 38 6 12%. Both the
peristent plaque CSA and the EEM CSA increased also
from after RA to after angioplasty.
The contribution of plaque removal, stent expansion and
plaque extrusion to the overall periprocedural lumen gain
was as follows: 1) plaque removal (during RA), 37 6 11%;
2) further stent expansion, 49 6 15%; 3) plaque extrusion
14 6 10 (during adjunct angioplasty).
Angiographic six-month follow-up and predictors for
recurrent restenosis. Angiographic follow-up was avail-
able in 40/45 (89%) patients. Recurrent restenosis was
observed in 18/40 patients (45%). Clinical follow-up after
6.6 6 2.5 months was available for all patients and revealed
a rate of recurrent revascularization of 38% (17/45). Four
variables were identified as predictors of recurrent restenosis
at six-month angiographic follow-up: percent diameter
stenosis before intervention (83 6 22% vs. 72 6 17%, p ,
0.01), stent length (40.5 6 21.3 mm vs. 21.5 6 14.1 mm,
p , 0.001), total lesion length (35.1 6 20.2 mm vs. 15.2 6
14.1 mm, p , 0.001) and the amount of neointimal recoil
after RA (23.2 6 13.6% vs. 8.9 6 8.3%, p , 0.001). The
only independent predictor by multivariate analysis, how-
ever, was neointimal recoil (p , 0.01, r2 5 0.44). Other
clinical (age, gender, diabetes, lesion location, stent type),
procedural (burr/artery ratio), angiographic (vessel size,
diameter stenosis) or IVUS variables (amount of plaque
ablation, intimal hyperplasia) were statistically not associ-
ated with recurrent angiographic restenosis.
Comparison of MLD measurements obtained by IVUS
and QCA analysis. All lesions with an angiographic MLD
less than the IVUS catheter (,1 mm) had to be excluded;
therefore, a subset of 18 lesions were included with regard to
preinterventional diameters. For comparative measurements
after RA and after adjunct angioplasty, the minimal lumen
diameters of all 49 lesions were available for analysis (Fig.
1). Simple linear regression analysis showed low correlation
coefficients between the two methods throughout the whole
procedure (r value: 0.39 to 0.57). The IVUS values before
intervention and after RA were systematically higher than
the corresponding angiographic values (Fig. 1 A and B). In
contrast, there was no systematic bias between QCA and
IVUS after adjunct angioplasty despite a low correlation
coefficient (r 5 0.39, Fig. 1 C).
DISCUSSION
The results of this study indicate that:
1. Rotablation effectively ablates in-stent plaque (IH) with-
out further stent expansion, stent destruction or external
vessel stretch.
2. The MLD after rotablation remains smaller than ex-
pected from the burr size used, indicating acute plaque
recoil.
3. Adjunct angioplasty after RA leads to additional lumen
gain by further stent expansion and, to a lesser extent,
plaque extrusion.
4. The rate of recurrent restenosis at six-month angio-
graphic follow-up is 45%, with a target vessel revascu-
larization rate of 40%. Lesion and stent length, smaller
lesion diameters and amount of acute neointimal recoil
after RA are predictors of recurrent restenosis at six-
month angiographic follow-up.
5. There is a low correlation between QCA and IVUS
analysis, especially for postinterventional measurements
and a systematic underestimation of the MLD by QCA
before intervention and after RA.
Mechanisms of “tissue-debulking” by rotablation for
in-stent restenosis. In the present study, planar IVUS
measurements revealed that RA effectively ablates in-stent
neointimal tissue and contributes 37 6 11% to the overall
procedural lumen gain when adjunct angioplasty is per-
formed. An example of the complex clinical situation is
shown in Figure 2. Neointima tissue usually is inhomoge-
neously distributed and the rotablator only removes those
portions of the plaque that are occlusive enough to be
accessible for the device (focal plaque ablation). Large
sections of the stent will not be effectively treated by the
burr, although there is significant plaque burden.
The MLD after RA assessed by IVUS was 15 6 4%
smaller than the burr diameter used, indicating acute neo-
intimal recoil; however, the mean lumen diameter after RA
was 10 6 5% larger. Most of this recoil occurred in our
experience in those stent segments with severe tissue burden
or even total occlusion before intervention. Additionally,
ineffective cutting sometimes results from fast “skipping” of
the burr into distal stent segments during the procedure.
Plaque recoil may be a significant phenomenon as it
obviously occurs in those segments of the lesion that have
already shown the strongest tendency for restenosis. In
addition, acute recoil quantitatively reduces the potential
ablating effect and the primary possible procedural success
of the rotablator and was also shown to be a risk factor for
recurrent restenosis in this study.
Similar phenomena have also been described for non-
stented, noncalcified lesions treated by RA (11,16). This is
in contrast to fibrotic and calcified lesions, in which effective
plaque removal without elastic recoil has been demonstrated
by IVUS (10). The differences between noncalcified and
calcified coronary lesions in their response to high speed
rotational atherectomy may be explained in part by the
principle of “differential cutting” by which the rotablator is
thought to act.
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Adjunct angioplasty after RA. Adjunct angioplasty after
RA contributes 63 6 16% to the overall procedural lumen
gain mainly by further stent expansion (77 6 14%) and, to
a smaller degree, by tissue extrusion through the stent struts
(23 6 11%). The residual mean and maximal area stenosis
after adjunct low pressure angioplasty are 30 6 19% and
38 6 12% respectively. The relatively high residual area
stenosis may be caused by the inflation pressure (7 6 1 atm)
used in this series of patients. This relatively low inflation
pressure was intended to reduce additional vessel trauma
with potentially beneficial long-term effects (recurrent re-
stenosis rates). Adjunct high pressure angioplasty
(.15 atm) might result in favorable acute angiographic
results; however, the postprocedural lesion diameter was not
a predictor of recurrent restenosis at six-month angio-
graphic follow-up.
Comparison with DCA and ELCA as alternative debulk-
ing techniques. Directional coronary atherectomy (DCA)
provides the only technique that may be able to completely
remove in-stent neointima; however, aggressive debulking
utilizing this device may be associated with stent destruction
(17,18). In contrast, RA did not result in stent destruction
or migration. Excimer laser coronary angioplasty (ELCA)
for in-stent restenosis results in a lower overall target vessel
revascularization rate compared with angioplasty alone,
supporting the concept of tissue debulking (19). The mech-
anisms of ELCA for the treatment of in-stent restenosis
have recently been described in detail with 29 6 15% of the
procedural lumen gain contributable to atheroablation (19),
compared with 37 6 11% when RA is used for debulking as
demonstrated in this study. Preliminary comparative data
also indicated that RA leads to a greater decrease in IH
volume than ELCA (20).
Figure 1. Comparison of minimal lumen diameter measurements obtained by intravascular ultrasound (IVUS) and quantitative coronary
angiography (QCA) before intervention (A), after rotational atherectomy (B) and after percutaneous transluminal coronary angioplasty
(PTCA) (C) using the Bland-Altman method. The individual differences between pairs of measurements (on the y-axis) are plotted against
the mean value of IVUS and QCA (on the x-axis). CI 5 confidence interval.
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Treatment of in-stent restenosis by angioplasty alone.
When angioplasty is used as a stand-alone procedure in the
treatment of in-stent restenosis, further stent expansion
quantitatively accounts for more than half of the total lumen
enlargement as compared with the decrease in neointimal
tissue burden (56 6 28% vs. 44 6 28%) (21). The amount
of tissue extrusion or compression induced by adjunct
angioplasty was smaller in the present series as RA induced
significant tissue ablation and therefore reduced the volume
of in-stent tissue available for extrusion/compression. In
addition, the maximal pressure used for adjunct angioplasty
in this study was lower (7 6 1 atm) than for angioplasty
alone (.10 atm) and the balloon size for adjunct angio-
plasty after RA was the same as for primary stent implan-
tation.
The restenosis rate after angioplasty of focal lesions is
reported to be as low as 22% (6). In lesions of intermediate
length (length: 8.93 6 7.30 mm), target vessel revascular-
ization rates are significantly higher (38%) (19). Rotational
atherectomy with adjunct angioplasty results in an improved
long-term clinical outcome compared with angioplasty
alone in the setting of diffuse ISR (clinical recurrence 25%
vs. 47% at six months) as reported in the first comparative
study (22). Additionally, in diffuse lesions treated by angio-
plasty alone, recurrent restenosis rates may be as high as
80% (8). In light of the latter results, a restenosis rate of 45%
in long lesions (22.4 6 20.2 mm) appears to be favorable;
however, additional antiproliferative pharmacotherapy or
intravascular brachytherapy may further improve long-term
outcome after treatment of ISR.
Predictors of recurrent restenosis. Based on the quanti-
tative analysis of the angiographic follow-up, stent and
lesion length and preinterventional diameter stenosis were
identified as predictors of recurrent restenosis after six
months. The predictive value of serial stent implantation,
and thereby lesion length, on restenosis rates has been
described for primary stent implantation (23) and turns out
to be a risk factor in the clinical setting of RA for in-stent
restenosis as well.
Most interestingly, the amount of acute neointimal
plaque recoil was also identified as a predictor of restenosis
after rotablation. Recoil after RA as an instantaneous
“restenosis” mechanism obviously reflects an unfavorable
lesion response to the rotablator for unknown reasons.
However, a high burr/artery ratio or the absolute amount
of tissue debulking, as suggested by Sharma et al. (24), could
not be proven to have beneficial effects on restenosis rates in
our small series of patients.
Study limitations.
1. Stents treated in this study comprised four types of stents
with different physical properties with regard to the
radial and longitudinal forces possibly influencing the
effects of adjunct angioplasty. The type of stent, however,
was not a predictor of recurrent restenosis.
2. This study reflects an operator learning curve with a
tendency to use smaller burr sizes and guiding catheters
in the first series of patients. Therefore, the amount of
RA-induced tissue ablation and the contribution of RA
to the overall procedural lumen gain may be higher in
Figure 2. Relation between in-stent neointima distribution and focal plaque ablation. Due to inhomogeneous plaque distribution and focal
neointima accumulation (1A, 1B) the minimal lumen diameter before rotablation ranges between 0.9 mm (1D) and 2.4 mm (1C) by
intravascular ultrasound. Rotational atherectomy (burr size 2.38 mm) does not induce further plaque ablation in those parts of the stent
with a larger lumen (2A, 2C), even though there is significant plaque burden. Focal plaque ablation (2B) leads to an increase in the minimal
lumen diameter and cross-sectional area as shown by intravascular ultrasound (2D); however, the final burr/lumen ratio .1 indicates acute
neointimal recoil.
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patients currently treated by RA with adjunct angio-
plasty.
3. The number of patients included in this study is still
relatively small; larger trials are needed to confirm the
present results and probably to identify further predictors
of recurrent restenosis.
4. The clinical and angiographic end point of this study was
at six months. The long-term outcome after RA of
in-stent restenosis is yet unknown.
5. There is no control group as all data were obtained in a
consecutive series of patients usually with long and
diffuse in-stent restenosis, in whom angioplasty as a
stand-alone procedure was not considered appropriate.
Conclusions. Rotational atherectomy of in-stent restenosis
leads to significant atheroma ablation of neointima support-
ing the concept of “tissue-debulking.” Angiographic resten-
osis is observed in 45% of patients with diffuse lesions. Stent
and lesion length, preinterventional diameter stenosis and
acute neointimal recoil are predictors of angiographic re-
stenosis. Differences between angioplasty as a stand-alone
procedure compared with RA with adjunct angioplasty and
other debulking techniques in the treatment of diffuse
in-stent restenosis are yet unknown. Several randomized
trials have been initiated to provide insight into the acute
and long-term effects of the different treatment modalities.
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